Identification and characterization of a potent peptide inhibitor targeting FOXM1 in cancer therapy.
Liang A, Chang M, Shang Z, Wang S, Huai R, Hua X, Wu D, Xiang K, Qi S, Jia S, Qi H, Jiang Y, Liu X, Mao C.
Liang A, et al. Among authors: jia s.
Biochem Pharmacol. 2025 Jun 23;240:117064. doi: 10.1016/j.bcp.2025.117064. Online ahead of print.
Biochem Pharmacol. 2025.
PMID: 40562125